Mildronate 250 mg Elbrus Pharmaceuticals

What Is Mildronate? A Metabolic Modulator for Research Mildronate is a synthetic metabolic modulator belonging to the class of carnitine biosynthesis inhibitors, first developed in Latvia during the 1970s and subsequently studied across a broad range of preclinical and clinical contexts. Marketed pharmaceutically as Meldonium, this compound operates by inhibiting the enzyme gamma-butyrobetaine hydroxylase, which curtails the final step of carnitine synthesis and thereby shifts cellular energy substrate utilisation from fatty acid oxidation toward more oxygen-efficient glucose metabolism. Researchers sourcing quality compounds for structured investigations will find the broader Research Compounds catalogue at uksteroidshops.co.uk an informative reference point for comparable agents. Research Applications and Investigative Context In preclinical models, Mildronate has been examined for its influence on myocardial ischaemia, cellular ATP conservation under hypoxic conditions, and mitochondrial respiratory chain activity. Studies in rodent models have explored its capacity to modulate carnitine-dependent fatty acid transport, reduce acylcarnitine accumulation, and attenuate reperfusion injury markers. Investigators studying energy-substrate partitioning in cardiac and skeletal muscle tissue have incorporated Mildronate as a pharmacological tool to probe these pathways. It has additionally appeared in neuroscience research, where its effects on dopaminergic neurotransmission and neuroprotection against excitotoxic insults have been evaluated in cell culture and in-vivo models. This 250 mg Elbrus Pharmaceuticals formulation offers researchers a standardised capsule format suited to consistent dosimetry in experimental protocols. Those also investigating androgenic compounds may find supplementary context across the oral steroids section of this site. For completeness, parenteral compound options are documented within the injectable steroids range, reflecting the diversity of research-grade materials available. Product Specifications Mildronate 250 mg — Elbrus Pharmaceuticals | Technical Data Parameter Detail Compound Mildronate (Meldonium) Manufacturer Elbrus Pharmaceuticals Strength per Unit 250 mg Form Capsule SKU ELB-PK-0651 CAS Number 76144-81-5 Molecular Formula C₆H₁₄N₂O₂ Molecular Weight 146.19 g/mol Storage Room temperature, dry environment, away from direct light Research Grade Yes — not for human consumption Compliance, Safety, and Purchasing Information Mildronate 250 mg from Elbrus Pharmaceuticals is supplied exclusively as a research compound for in-vitro and preclinical laboratory use. It is not intended for human consumption, and no information on this page constitutes medical advice or a dosing recommendation. Researchers evaluating this compound as part of structured metabolic or cardiovascular studies should review all applicable institutional and regulatory guidelines prior to procurement. Visit the uksteroidshops.co.uk homepage for full terms of sale and compliance documentation. Must be 18 or older to purchase. Adhere to all local and national legislation governing research chemical acquisition and use.